FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362716781> ?p ?o ?g. }

• W4362716781 endingPage "2244" @default.
• W4362716781 startingPage "2235" @default.
• W4362716781 abstract "Abstract Purpose This study compares the efficacy and safety of lenvatinib and programmed cell death protein (PD)‐1 versus lenvatinib alone for advanced hepatocellular carcinoma (Ad‐HCC) refractory to hepatic arterial infusion chemotherapy (HAIC). Methods From April 2016 to September 2021, 145 patients with Ad‐HCC refractory to HAIC based on modified Response Evaluation Criteria in Solid Tumors criteria were enrolled by two radiologists and classified into the HAIC‐lenvatinib group (H‐L, n = 87) and HAIC‐lenvatinib‐PD‐1 group (H‐L‐P, n = 58). A propensity score‐matching method was used to reduce selective bias. The overall survival (OS) and postprogression‐free survival (PPS) rates were compared using the Kaplan–Meier method with log‐rank test. Multivariable analyses of independent prognostic factors were evaluated by means of the forward stepwise Cox regression model. Results After propensity score matching 1:1, the median OS was 43.6 months in the H‐L‐P group and was significantly longer than that (18.9 months) of the H‐L group ( p = .009). The median PPS was 35.6 months in the H‐L‐P group and was significantly longer than that (9.4 months) of the H‐L group ( p = .009). Multivariate analyses showed that the factors that ‎significantly affected the OS were‎ α‐fetoprotein (hazard ratio [HR], 2.14; 95% CI, 1.26–3.98; p = .006), early response to HAIC (HR, 0.44; 95% CI, 1.20–3.85; p = .009), and H‐L treatment (HR, ‎0.52; 95% CI, 0.30–0.86; p = .012). Modified albumin‐bilirubin grade (HR, 1.32; 95% CI, 1.03–1.70; p = .026), early response to HAIC (HR, 0.44; 95% CI, 0.25–0.77; p = .004), and H‐L (HR, ‎0.47‎; 95% CI, 0.28–0.78; p = .003) significantly affected the PPS. Conclusions This combination therapy of PD‐1 inhibitors plus lenvatinib has promising survival benefits in the management of patients with Ad‐HCC refractory to HAIC. Plain Language Summary Lenvatinib plus programmed death 1 inhibitor is an effective and safe postprogression treatment and improved significantly overall survival and postprogression‐free survival compared with lenvatinib alone in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy." @default.
• W4362716781 created "2023-04-09" @default.
• W4362716781 creator A5033709535 @default.
• W4362716781 creator A5038773613 @default.
• W4362716781 creator A5040027560 @default.
• W4362716781 creator A5077844760 @default.
• W4362716781 creator A5088926848 @default.
• W4362716781 date "2023-04-07" @default.
• W4362716781 modified "2023-10-12" @default.
• W4362716781 title "Postprogression treatment of lenvatinib plus PD‐1 inhibitor in advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy" @default.
• W4362716781 cites W1983517349 @default.
• W4362716781 cites W2156906256 @default.
• W4362716781 cites W2179494416 @default.
• W4362716781 cites W2277004004 @default.
• W4362716781 cites W2582878252 @default.
• W4362716781 cites W2612400171 @default.
• W4362716781 cites W2789635905 @default.
• W4362716781 cites W2796067155 @default.
• W4362716781 cites W2990602950 @default.
• W4362716781 cites W2994991018 @default.
• W4362716781 cites W3021228866 @default.
• W4362716781 cites W3025022288 @default.
• W4362716781 cites W3096339202 @default.
• W4362716781 cites W3128646645 @default.
• W4362716781 cites W3173064115 @default.
• W4362716781 cites W3201603777 @default.
• W4362716781 cites W4200240365 @default.
• W4362716781 cites W4200420421 @default.
• W4362716781 cites W4213096024 @default.
• W4362716781 cites W4226253134 @default.
• W4362716781 cites W4291782368 @default.
• W4362716781 cites W4292546829 @default.
• W4362716781 cites W4295812868 @default.
• W4362716781 cites W4307261665 @default.
• W4362716781 doi "https://doi.org/10.1002/cncr.34764" @default.
• W4362716781 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37029486" @default.
• W4362716781 hasPublicationYear "2023" @default.
• W4362716781 type Work @default.
• W4362716781 citedByCount "2" @default.
• W4362716781 countsByYear W43627167812023 @default.
• W4362716781 crossrefType "journal-article" @default.
• W4362716781 hasAuthorship W4362716781A5033709535 @default.
• W4362716781 hasAuthorship W4362716781A5038773613 @default.
• W4362716781 hasAuthorship W4362716781A5040027560 @default.
• W4362716781 hasAuthorship W4362716781A5077844760 @default.
• W4362716781 hasAuthorship W4362716781A5088926848 @default.
• W4362716781 hasConcept C121332964 @default.
• W4362716781 hasConcept C126322002 @default.
• W4362716781 hasConcept C142424586 @default.
• W4362716781 hasConcept C143998085 @default.
• W4362716781 hasConcept C17923572 @default.
• W4362716781 hasConcept C207103383 @default.
• W4362716781 hasConcept C2776264508 @default.
• W4362716781 hasConcept C2778019345 @default.
• W4362716781 hasConcept C2778695046 @default.
• W4362716781 hasConcept C44249647 @default.
• W4362716781 hasConcept C50382708 @default.
• W4362716781 hasConcept C71924100 @default.
• W4362716781 hasConcept C87355193 @default.
• W4362716781 hasConcept C90924648 @default.
• W4362716781 hasConceptScore W4362716781C121332964 @default.
• W4362716781 hasConceptScore W4362716781C126322002 @default.
• W4362716781 hasConceptScore W4362716781C142424586 @default.
• W4362716781 hasConceptScore W4362716781C143998085 @default.
• W4362716781 hasConceptScore W4362716781C17923572 @default.
• W4362716781 hasConceptScore W4362716781C207103383 @default.
• W4362716781 hasConceptScore W4362716781C2776264508 @default.
• W4362716781 hasConceptScore W4362716781C2778019345 @default.
• W4362716781 hasConceptScore W4362716781C2778695046 @default.
• W4362716781 hasConceptScore W4362716781C44249647 @default.
• W4362716781 hasConceptScore W4362716781C50382708 @default.
• W4362716781 hasConceptScore W4362716781C71924100 @default.
• W4362716781 hasConceptScore W4362716781C87355193 @default.
• W4362716781 hasConceptScore W4362716781C90924648 @default.
• W4362716781 hasIssue "14" @default.
• W4362716781 hasLocation W43627167811 @default.
• W4362716781 hasLocation W43627167812 @default.
• W4362716781 hasOpenAccess W4362716781 @default.
• W4362716781 hasPrimaryLocation W43627167811 @default.
• W4362716781 hasRelatedWork W2331208202 @default.
• W4362716781 hasRelatedWork W2993061990 @default.
• W4362716781 hasRelatedWork W3008216473 @default.
• W4362716781 hasRelatedWork W3008495314 @default.
• W4362716781 hasRelatedWork W3025508748 @default.
• W4362716781 hasRelatedWork W3122656440 @default.
• W4362716781 hasRelatedWork W4205110801 @default.
• W4362716781 hasRelatedWork W4292683646 @default.
• W4362716781 hasRelatedWork W4310710346 @default.
• W4362716781 hasRelatedWork W3162568057 @default.
• W4362716781 hasVolume "129" @default.
• W4362716781 isParatext "false" @default.
• W4362716781 isRetracted "false" @default.
• W4362716781 workType "article" @default.